Dr. Fraser's research is focused on the discovery and validation of diagnostic and prognostic biomarkers for complex diseases, including renal dysfunction, long-COVID, and sepsis. By leveraging ...

Collaboration to leverage Lunit SCOPE IO ® and SCOPE universal IHC® (uIHC) digital pathology products in two Daiichi Sankyo oncology research ...

Join us for a science symposium where cutting-edge biology meets transformative technology. Dive deep into molecular research using the latest multiomics advances, from the granularity of single-cell ...

DALLAS--(BUSINESS WIRE)--ESYA Labs, a global leader in lysosomal biology and biomarker discovery for neurodegenerative diseases, has announced a transformative partnership with Alamar Biosciences, a ...

LOS ANGELES, April 09, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer ...

Precision medicine has revolutionized the landscape of neurological care, shifting from “one-size-fits-all” approaches to ...

For much of the past century, Alzheimer's disease has been one of medicine's most daunting frontiers—biologically complex, ...

The identification of circulating biomarkers that are closely correlated with Parkinson's disease (PD) has failed several times in the past. This webcast will present an adaptation of a translational ...

Great. Good morning, everyone. I'm Alexandra Byrne. I'm a reporter at GenomeWeb, and I will be your moderator for today's webinar. The title of today's webinar is beyond the genome: Measuring ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." It may feel nearly impossible to scroll through social media these days without seeing ads for trendy, ...

The TO_AITION project, completed this month (December 2025), has been investigating the biological causes of inflammation ...